Marex Group’s MetLife MET Stock Holding History

Marex Group’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,112	Closed	-$246K	–	1169
2025 Q4	$246K	Buy	+3,112	New	+$246K	﹤0.01%	777
2025 Q3	–	Sell	-8,256	Closed	-$664K	–	954
2025 Q2	$664K	Buy	+8,256	New	+$637K	0.01%	344
2024 Q2	–	Sell	-141,292	Closed	-$10.5M	–	683
2024 Q1	$10.5M	Buy	+141,292	New	+$9.85M	0.34%	53

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marex Group's MET Position: Q1 2026 in Review

Marex Group sold out of MetLife (MET) in Q1 2026, closing a stake of 3,112 shares — an estimated $246K sold.

Marex Group first reported a position in MET in Q1 2024 and held it in 3 quarters. The position peaked at $10.5M in Q1 2024. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Marex Group reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Marex Group sold 3,112 MetLife shares in Q1 2026, an estimated $246K.
Marex Group first reported a position in MetLife in Q1 2024 and held it in 3 quarters.
Marex Group's MetLife position peaked at $10.5M in Q1 2024.
1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.